journal article·2022-02-23

Weighing the DNA Content of Adeno-Associated Virus Vectors with Zeptogram Precision Using Nanomechanical Resonators

Georgios Katsikis, Iris E. Hwang, Wade Wang, Vikas S. Bhat, Nicole L. McIntosh, Omair A. Karim, Bartlomiej J. Blus, Sha Sha, Vincent Agache, Jacqueline M. Wolfrum, Stacy L. Springs, Anthony J. Sinskey, Paul W. Barone, Richard D. Braatz, Scott R. Manalis

Nano Letters· Volume 22· Issue 4
Publisher page

Abstract

Quantifying the composition of viral vectors used in vaccine development and gene therapy is critical for assessing their functionality. Adeno-associated virus (AAV) vectors, which are the most widely used viral vectors for in vivo gene therapy, are typically characterized using PCR, ELISA, and analytical ultracentrifugation which require laborious protocols or hours of turnaround time. Emerging methods such as charge-detection mass spectroscopy, static light scattering, and mass photometry offer turnaround times of minutes for measuring AAV mass using optical or charge properties of AAV. Here, we demonstrate an orthogonal method where suspended nanomechanical resonators (SNR) are used to directly measure both AAV mass and aggregation from a few microliters of sample within minutes. We achieve a precision near 10 zeptograms which corresponds to 1% of the genome holding capacity of the AAV capsid. Our results show the potential of our method for providing real-time quality control of viral vectors during biomanufacturing.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Virus-based gene therapy research · Viral Infectious Diseases and Gene Expression in Insects · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

BioMarin Pharmaceutical, Inc., Novato, California 94949, United States

BioMarin Pharmaceutical, Inc., San Rafael, California 94901, United States

Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Université Grenoble Alpes, CEA, LETI, 38000, Grenoble, France

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

Funding

Massachusetts Life Sciences Center · U.S. Food and Drug Administration · Virginia and D.K. Ludwig Fund for Cancer Research

References (36)

Show source-provided references
1. 10.1038/s41576-019-0205-410.1038/s41576-019-0205-4 ↗
2. 10.1038/mtm.2016.210.1038/mtm.2016.2 ↗
3. 10.1038/s41598-019-49624-w10.1038/s41598-019-49624-w ↗
4. 10.1038/d41573-021-00164-x10.1038/d41573-021-00164-x ↗
5. 10.1016/j.omtm.2021.02.01010.1016/j.omtm.2021.02.010 ↗
6. 10.1021/acs.analchem.6b0088310.1021/acs.analchem.6b00883 ↗
7. 10.1021/acs.analchem.0c0213310.1021/acs.analchem.0c02133 ↗
8. 10.1038/s41592-020-0770-710.1038/s41592-020-0770-7 ↗
9. 10.1016/j.omtm.2021.11.01310.1016/j.omtm.2021.11.013 ↗
10. 10.1021/ac500185w10.1021/ac500185w ↗
11. 10.1038/s41598-021-82599-110.1038/s41598-021-82599-1 ↗
12. 10.1021/acsphotonics.6b0091210.1021/acsphotonics.6b00912 ↗
13. 10.1126/science.aar583910.1126/science.aar5839 ↗
14. 10.1038/s41434-021-00311-410.1038/s41434-021-00311-4 ↗
15. 10.1093/nar/gkaa63210.1093/nar/gkaa632 ↗
16. 10.1038/nature0574110.1038/nature05741 ↗
17. 10.1021/acssensors.0c0039410.1021/acssensors.0c00394 ↗
18. 10.1063/1.280407410.1063/1.2804074 ↗
19. 10.1073/pnas.131860211110.1073/pnas.1318602111 ↗
20. 10.1128/jvi.6.3.363-369.197010.1128/jvi.6.3.363-369.1970 ↗
21. 10.1128/JVI.01415-1310.1128/JVI.01415-13 ↗
22. 10.1128/JVI.00867-1310.1128/JVI.00867-13 ↗
23. 10.1038/nnano.2012.4210.1038/nnano.2012.42 ↗
24. 10.1039/C3LC51058A10.1039/C3LC51058A ↗
25. 10.1063/1.493715110.1063/1.4937151 ↗
26. 10.1007/s12551-016-0218-610.1007/s12551-016-0218-6 ↗
27. 10.1038/s41467-021-25266-310.1038/s41467-021-25266-3 ↗
28. 10.1016/j.ymthe.2005.02.02110.1016/j.ymthe.2005.02.021 ↗
29. 10.1146/annurev.fluid.36.050802.12212410.1146/annurev.fluid.36.050802.122124 ↗
30. 10.1016/S1525-0016(02)00019-910.1016/S1525-0016(02)00019-9 ↗
31. 10.1128/JVI.80.4.1874-1885.200610.1128/JVI.80.4.1874-1885.2006 ↗
32. 10.1002/cem.134310.1002/cem.1343 ↗
33. 10.1007/s10337-017-3380-510.1007/s10337-017-3380-5 ↗
34. 10.1016/j.omtm.2019.09.00610.1016/j.omtm.2019.09.006 ↗
35. 10.1016/j.biotechadv.2021.10776410.1016/j.biotechadv.2021.107764 ↗
36. 10.1016/j.omtm.2021.04.00610.1016/j.omtm.2021.04.006 ↗